Article Text

PDF
‘Not all drugs (and route) are same’
  1. Abhishek Arvind Zanwar
  1. Senior Resident, Department of Clinical Immunology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
  1. Correspondence to Dr Abhishek Arvind Zanwar, Senior Resident, Department of Clinical Immunology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh 226014, India; abhishek.zanwar{at}gmail.com

Statistics from Altmetric.com

I read with great interest, study by French vasculitis group, the MAINRITSAN 2 trial.1 The results of this trial again underline our limitations for search of biomarker, which can predict relapse of antineutrophil cytoplasmic autoantibodies (ANCA)-associated vasculitis. I have few concerns about details and analysis regarding induction regime used in …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles